Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

May 9, 2018

Study Completion Date

May 9, 2018

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b (Betaferon, BAY86-5046)

Solution for injection

DEVICE

Betaconnect auto-injector

Auto-injector for application of Betaferon solution which automatically covers injection related data

DEVICE

myBETAapp

Medical device which can be connected with Betaconnect auto-injector and displays injection related data to patients and offers tracking of patient reported data at the wellness- tracker

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY